Product Code: ETC9929995 | Publication Date: Sep 2024 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United Arab Emirates (UAE) pertussis market is characterized by a growing awareness of the importance of vaccination in preventing this highly contagious respiratory disease, also known as whooping cough. The market is primarily driven by increasing government initiatives to promote vaccination programs, rising healthcare infrastructure development, and growing investments in research and development activities. The demand for pertussis vaccines is expected to rise steadily due to the rising incidence of pertussis cases and the emphasis on immunization to protect vulnerable populations such as infants, pregnant women, and the elderly. Key players in the UAE pertussis market include pharmaceutical companies offering a range of vaccines to combat this disease, with a focus on developing innovative formulations and expanding their distribution networks to reach a wider population.
The Pertussis market in the United Arab Emirates is experiencing a growing demand for vaccines and treatments due to increasing awareness about the disease and the importance of vaccination. The market is witnessing a shift towards combination vaccines that offer protection against multiple diseases, including Pertussis, in a single shot, thereby reducing the number of injections required. Furthermore, there is a focus on developing innovative formulations and delivery methods to improve vaccine efficacy and patient compliance. With a rising emphasis on preventive healthcare and government initiatives to promote vaccination programs, the Pertussis market in the UAE is expected to continue to expand, driven by a growing population and increasing healthcare expenditure.
In the United Arab Emirates (UAE) Pertussis market, some key challenges include low awareness about the importance of vaccination against Pertussis, limited access to healthcare services in remote areas, and potential gaps in surveillance and reporting of Pertussis cases. Additionally, there may be issues related to the availability and affordability of Pertussis vaccines, as well as potential hesitancy among some segments of the population towards vaccination. Addressing these challenges would require a comprehensive approach involving public health campaigns to raise awareness, improving healthcare infrastructure and services in underserved areas, strengthening surveillance systems, and ensuring the availability and affordability of Pertussis vaccines across the country.
The United Arab Emirates (UAE) pertussis market presents promising investment opportunities due to the increasing focus on vaccination programs and public health initiatives. With a growing population and rising awareness about the importance of immunization, there is a growing demand for pertussis vaccines in the UAE. Investing in pharmaceutical companies that specialize in vaccine production or distribution in the region could be a lucrative opportunity. Additionally, partnering with healthcare providers or government agencies to support vaccination campaigns and programs can also be a strategic investment in the UAE pertussis market. As the country continues to prioritize healthcare infrastructure and disease prevention, there is a favorable environment for investments in the pertussis market in the UAE.
The United Arab Emirates (UAE) has implemented robust vaccination policies to prevent and control pertussis, commonly known as whooping cough. The UAE Ministry of Health and Prevention (MOHAP) provides free pertussis vaccines to all residents, particularly focusing on children and pregnant women. The National Immunization Program includes the DTaP (diphtheria, tetanus, and pertussis) vaccine as part of routine childhood vaccinations. Additionally, the UAE government has stringent regulations in place to ensure the safety and efficacy of vaccines distributed in the country. These policies aim to reduce the incidence of pertussis and protect the population, especially vulnerable groups, from this contagious respiratory disease.
The United Arab Emirates (UAE) pertussis market is expected to witness steady growth in the coming years due to increasing awareness about the importance of vaccination and the country`s strong healthcare infrastructure. The market is projected to be driven by rising government initiatives to promote immunization programs and combat infectious diseases. Additionally, the growing focus on preventive healthcare measures and the introduction of new and improved vaccines are anticipated to further boost the market. With a growing population and increasing healthcare expenditure, the UAE pertussis market is likely to experience sustained growth as healthcare providers and policymakers continue to prioritize vaccination efforts to protect public health.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Pertussis Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Pertussis Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Pertussis Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Pertussis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Pertussis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Pertussis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Pertussis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 United Arab Emirates (UAE) Pertussis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Arab Emirates (UAE) Pertussis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Pertussis Market Trends |
6 United Arab Emirates (UAE) Pertussis Market, By Types |
6.1 United Arab Emirates (UAE) Pertussis Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Chest X-Ray, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Nose or Throat Culture & Test, 2021- 2031F |
6.1.6 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Arab Emirates (UAE) Pertussis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Supportive Treatments, 2021- 2031F |
6.2.5 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Arab Emirates (UAE) Pertussis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Arab Emirates (UAE) Pertussis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Arab Emirates (UAE) Pertussis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United Arab Emirates (UAE) Pertussis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Arab Emirates (UAE) Pertussis Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Pertussis Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Pertussis Market Imports from Major Countries |
8 United Arab Emirates (UAE) Pertussis Market Key Performance Indicators |
9 United Arab Emirates (UAE) Pertussis Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Pertussis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Pertussis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Pertussis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Pertussis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 United Arab Emirates (UAE) Pertussis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Arab Emirates (UAE) Pertussis Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Pertussis Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Pertussis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |